Cargando…

Platelet Activity and Cardiovascular Risk in CKD and Peripheral Artery Disease

INTRODUCTION: Platelet dysfunction and cardiovascular risk are well-recognized features of chronic kidney disease (CKD). Platelets drive the development and progression of cardiovascular disease (CVD). The relationships between kidney function, platelet activity, and cardiovascular risk are poorly d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cofer, Lucas B., Soomro, Qandeel H., Xia, Yuhe, Luttrell-Williams, Elliot, Myndzar, Khrystyna, Charytan, David M., Berger, Jeffrey S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546761/ https://www.ncbi.nlm.nih.gov/pubmed/36217517 http://dx.doi.org/10.1016/j.ekir.2022.07.169

Ejemplares similares

SOLUBLE P-SELECTIN, PLATELET ACTIVITY AND RISK OF MORBIDITY AND MORTALITY IN COVID-19
por: Mosarla, Ramya, et al.
Publicado: (2022)

Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype
por: Cornwell, MacIntosh G., et al.
Publicado: (2023)

Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis
por: Mavrakanas, Thomas A., et al.
Publicado: (2022)

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
por: Cornwell, MacIntosh Grant, et al.
Publicado: (2021)

Platelets amplify endotheliopathy in COVID-19
por: Barrett, Tessa J., et al.
Publicado: (2021)

Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach
por: Cofer, Lucas B., et al.
Publicado: (2022)

CKD Effects on Platelets: Implications for Cardiovascular Risk
por: Baaten, Constance C.F.M.J., et al.
Publicado: (2022)

All-Cause Mortality and Progression to End-Stage Kidney Disease Following Percutaneous Revascularization or Surgical Coronary Revascularization in Patients with CKD
por: Charytan, David M., et al.
Publicado: (2021)

Progression of Medial Arterial Calcification in CKD
por: Manzoor, Shumila, et al.
Publicado: (2018)

Gender Disparities in Nephrology Trials: A Meta-Analysis of Enrollment Trends between 2000 and 2021
por: Soomro, Qandeel H., et al.
Publicado: (2023)

Cardiovascular Risk Factor Burden and Association With CKD in Ghana and Nigeria
por: Olanrewaju, Timothy O., et al.
Publicado: (2022)

Utilization of Palliative Care for Patients with Acute Kidney Injury and COVID-19 (S541)
por: Scherer, Jennifer, et al.
Publicado: (2022)

Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients
por: Ramspek, Chava L., et al.
Publicado: (2022)

Augmentation Index Derived from Peripheral Arterial Tonometry Correlates with Cardiovascular Risk Factors
por: Patvardhan, Eshan, et al.
Publicado: (2011)

Intravenous Iron Repletion Does Not Significantly Decrease Platelet Counts in CKD Patients with Iron Deficiency Anemia
por: Dossabhoy, Neville R., et al.
Publicado: (2013)

Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD
por: Mavrakanas, Thomas A., et al.
Publicado: (2018)

Educational Attainment Is Associated With Kidney and Cardiovascular Outcomes in the German CKD (GCKD) Cohort
por: Winitzki, Doris, et al.
Publicado: (2022)

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology
por: Venuthurupalli, Sree K., et al.
Publicado: (2018)

Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes
por: Cabrera, Claudia S., et al.
Publicado: (2020)

Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD
por: Li, Kevin, et al.
Publicado: (2020)

Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD
por: Sommerer, Claudia, et al.
Publicado: (2023)

Profile of Cardiovascular Risk Factors and Mortality in Patients with Symptomatic Peripheral Arterial Disease
por: Zanati, Silméia Garcia, et al.
Publicado: (2009)

Impact of CKD on Household Income
por: Morton, Rachael L., et al.
Publicado: (2017)

Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts
por: Canney, Mark, et al.
Publicado: (2023)

Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR
por: Arshad, Adam, et al.
Publicado: (2021)

Plasma Biomarkers as Risk Factors for Incident CKD
por: Sarnak, Mark J., et al.
Publicado: (2022)

NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients
por: Maruyama, Sonomi, et al.
Publicado: (2020)

Early Identification of CKD—A Scoping Review of the Global Populations
por: Okpechi, Ikechi G., et al.
Publicado: (2022)

Metabolic Acidosis and Cardiovascular Disease in CKD
por: Collister, David, et al.
Publicado: (2021)

Cardiovascular disease in older women with CKD
por: Radley, Alice, et al.
Publicado: (2023)

Echocardiography to Screen for Pulmonary Hypertension in CKD
por: Edmonston, Daniel L., et al.
Publicado: (2020)

Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease
por: Barrett, Tessa J., et al.
Publicado: (2020)

Risk factors analysis for hyperuricemic nephropathy among CKD stages 3–4 patients: an epidemiological study of hyperuricemia in CKD stages 3–4 patients in Ningbo, China
por: Wu, Yong-Yao, et al.
Publicado: (2018)

Health-Related Quality of Life in People Across the Spectrum of CKD
por: Krishnan, Anoushka, et al.
Publicado: (2020)

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda
por: Fliser, Danilo, et al.
Publicado: (2011)

Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis
por: Brightwell, Camille R., et al.
Publicado: (2021)

Prevalence of CKD, Diabetes, and Hypertension in Rural Tanzania
por: Ploth, David W., et al.
Publicado: (2018)

Self-reported Medication Adherence and CKD Progression
por: Cedillo-Couvert, Esteban A., et al.
Publicado: (2018)

APOL1, Acid Load, and CKD Progression
por: Pike, Mindy, et al.
Publicado: (2019)

Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD
por: Wiles, Kate, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a2n37bbrkvc3j2sgvk8ffq40iq